Virtus LifeSci Biotech Products ETF Rating → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free BBP Stock Alerts $53.29 +1.22 (+2.34%) (As of 07:45 AM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy2.72Holdings in BBP have an aggregate rating of Moderate Buy based on 560 analyst ratings issued in the past year covering 50 companies (98.2% of the portfolio).BBP Aggregate Price Target$84.0361.38% UpsideHigh Prediction$127.03Average Prediction$84.03Low Prediction$60.24Holdings in BBP have an aggregate price target of $84.03 and a range of $60.24 to $127.03 covering 50 companies (98.2% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BBP Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.79%TARSTarsus Pharmaceuticals$32.04-0.5%3 of 5 stars2.88$48.38 51.0%83.07%ADMAADMA Biologics$6.60+0.8%2 of 5 stars3.25$7.88 19.3%4Short Interest ↑2.98%LXRXLexicon Pharmaceuticals$1.61+1.9%2 of 5 stars2.00$5.00 210.6%1News Coverage2.61%AGIOAgios Pharmaceuticals$31.49-0.6%1 of 5 stars2.50$33.50 6.4%4Upcoming Earnings2.59%SRPTSarepta Therapeutics$128.77+1.1%4 of 5 stars2.79$156.60 21.6%14Upcoming Earnings2.54%SWTXSpringWorks Therapeutics$45.53+3.0%2 of 5 stars3.00$68.00 49.4%6Upcoming Earnings2.51%ASNDAscendis Pharma A/S$135.90-0.8%2 of 5 stars2.88$173.25 27.5%8Short Interest ↑2.51%MRNAModerna$107.80-0.2%4 of 5 stars2.25$126.49 17.3%16Upcoming EarningsInsider Selling2.44%LGNDLigand Pharmaceuticals$70.57+0.3%5 of 5 stars3.00$116.33 64.8%3Upcoming EarningsShort Interest ↑2.25%NBIXNeurocrine Biosciences$135.99-1.3%5 of 5 stars2.74$142.38 4.7%23Upcoming EarningsShort Interest ↓2.13%REGNRegeneron Pharmaceuticals$883.20-0.8%5 of 5 stars2.70$977.77 10.7%20Upcoming Earnings2.12%KNSAKiniksa Pharmaceuticals$17.88+1.5%3 of 5 stars3.00$30.00 67.8%2Earnings Report2.11%BPMCBlueprint Medicines$93.00+2.5%1 of 5 stars2.50$91.57 -1.5%14Upcoming EarningsAnalyst ReportNews CoverageGap Up2.05%APLSApellis Pharmaceuticals$49.86+4.0%4 of 5 stars2.87$77.93 56.3%15Analyst ReportGap Up2.05%ITCIIntra-Cellular Therapies$73.26+1.6%4 of 5 stars2.90$90.17 23.1%10Upcoming EarningsAnalyst Revision2.03%HALOHalozyme Therapeutics$38.57+0.3%5 of 5 stars2.86$53.29 38.2%72.03%VRTXVertex Pharmaceuticals$396.39-0.3%4 of 5 stars2.48$429.45 8.3%23Upcoming Earnings2.02%ROIVRoivant Sciences$11.03+1.4%4 of 5 stars2.90$16.90 53.2%10Short Interest ↑2.02%EXELExelixis$23.70+0.7%5 of 5 stars2.60$26.29 10.9%15Upcoming EarningsShort Interest ↑Analyst Revision1.99%AMGNAmgen$270.40+0.2%5 of 5 stars2.53$297.40 10.0%19Upcoming Earnings1.95%DCPHDeciphera Pharmaceuticals$25.08+71.2%4 of 5 stars2.80$23.00 -8.3%5Upcoming EarningsShort Interest ↓News CoverageGap UpTrading HaltedHigh Trading Volume1.94%BMRNBioMarin Pharmaceutical$80.91-1.5%5 of 5 stars2.63$107.50 32.9%19Analyst ReportShort Interest ↑Analyst Revision1.94%RYTMRhythm Pharmaceuticals$38.28+0.3%2 of 5 stars3.00$47.20 23.3%5Analyst Report1.94%RAREUltragenyx Pharmaceutical$44.24+0.9%4 of 5 stars2.92$88.08 99.1%12Upcoming Earnings1.93%PTCTPTC Therapeutics$28.57+12.1%3 of 5 stars1.85$33.53 17.4%13Earnings ReportAnalyst Upgrade1.93%AXSMAxsome Therapeutics$74.37+3.7%4 of 5 stars2.92$119.67 60.9%13Upcoming Earnings1.93%CRSPCRISPR Therapeutics$54.36+0.8%3 of 5 stars2.38$76.29 40.3%161.92%INSMInsmed$24.80-0.5%4 of 5 stars3.00$44.92 81.1%12Upcoming Earnings1.92%UTHRUnited Therapeutics$233.85-0.9%5 of 5 stars2.89$294.25 25.8%9Upcoming Earnings1.87%TBPHTheravance Biopharma$9.12-0.2%2 of 5 stars3.00$20.50 124.8%2Short Interest ↓News CoveragePositive News1.81%HRMYHarmony Biosciences$29.32+1.3%4 of 5 stars2.50$40.63 38.6%8Upcoming Earnings1.80%IMCRImmunocore$58.46+0.8%3 of 5 stars2.85$81.50 39.4%14Short Interest ↓1.77%FOLDAmicus Therapeutics$10.28+1.1%4 of 5 stars3.00$20.00 94.6%3Positive News1.75%BNTXBioNTech$87.57+0.4%4 of 5 stars2.30$120.40 37.5%10Upcoming Earnings1.75%LEGNLegend Biotech$45.30+2.0%2 of 5 stars2.92$82.64 82.4%121.73%IONSIonis Pharmaceuticals$40.71-2.1%4 of 5 stars2.69$56.08 37.7%13Positive News1.73%INCYIncyte$51.68+1.0%5 of 5 stars2.44$75.50 46.1%16Upcoming Earnings1.72%GILDGilead Sciences$64.60-1.3%5 of 5 stars2.35$83.87 29.8%17Earnings ReportDividend AnnouncementAnalyst ReportShort Interest ↓Analyst Revision1.64%ALNYAlnylam Pharmaceuticals$143.31-0.3%5 of 5 stars2.59$215.88 50.6%17Upcoming EarningsAnalyst UpgradeShort Interest ↓1.59%BIIBBiogen$208.90+3.2%5 of 5 stars2.67$293.88 40.7%27Earnings ReportShort Interest ↓Analyst Revision1.53%BGNEBeiGene$153.58+3.4%3 of 5 stars2.80$250.13 62.9%10Upcoming EarningsShort Interest ↑Analyst RevisionGap Up1.52%TVTXTravere Therapeutics$5.41+2.9%1 of 5 stars2.60$18.00 232.7%15Upcoming EarningsAnalyst Revision1.51%BCRXBioCryst Pharmaceuticals$4.18+0.5%4 of 5 stars3.00$13.83 230.9%6Upcoming EarningsShort Interest ↑1.50%SAGESage Therapeutics$13.69+0.8%4 of 5 stars2.12$37.72 175.5%17Earnings ReportAnalyst ReportAnalyst RevisionNews CoverageGap Up1.49%BBIOBridgeBio Pharma$24.88+2.3%4 of 5 stars2.80$47.82 92.2%10Upcoming EarningsShort Interest ↑1.43%MIRMMirum Pharmaceuticals$24.46-0.1%4 of 5 stars3.11$51.70 111.4%9Upcoming Earnings1.41%IRWDIronwood Pharmaceuticals$7.82-3.2%4 of 5 stars3.00$19.80 153.2%51.25%ACADACADIA Pharmaceuticals$16.71+2.5%4 of 5 stars2.80$32.13 92.3%151.16%AUPHAurinia Pharmaceuticals$4.93+0.4%2 of 5 stars2.75$10.00 102.8%4Upcoming EarningsShort Interest ↓0.97%ZLABZai Lab$15.91+1.1%2 of 5 stars3.00$64.22 303.7%5Positive News This page (NYSEARCA:BBP) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
